Skip to content

OnKure Therapeutics, Inc. OKUR Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Pfizer logo
PfizerPFE
Eikon Therapeutics, Inc.
 logo
Eikon Therapeutics, Inc. EIKN
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
Replimune Group logo
Replimune GroupREPL
Erasca, Inc. logo
Erasca, Inc.ERAS
Arcus Biosciences logo
Arcus BiosciencesRCUS

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+72.6%
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s software and technology licenses, net?
OnKure Therapeutics, Inc. (OKUR) reported software and technology licenses, net of $405K in Q1 2026.
How has OnKure Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
OnKure Therapeutics, Inc.'s software and technology licenses, net increased by 271.6% year-over-year, from $109K to $405K.
What is the long-term trend for OnKure Therapeutics, Inc.'s software and technology licenses, net?
Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s software and technology licenses, net has grown at a 16.5% compound annual growth rate (CAGR), from $127K to $273K.